NEW YORK, NY — AllazoHealth, the pioneer in delivering AI-driven healthcare experiences, has been selected by PM360 as part of its prestigious annual Innovations Issue, which highlights the most forward-thinking advancements in the life sciences, healthcare, and marketing in 13 categories. AllazoHealth was included in the Artificial Intelligence (AI) category, which includes AI/ML companies or products that are helping to improve healthcare and the life sciences. The innovations featured were selected among hundreds of submissions and represent both real-life use cases of available products and services as well as promising developments worth keeping an eye on.
AllazoHealth empowers pharmaceutical organizations to personalize interventions and create the optimal experience for each individual, maximizing the impact and efficiency of pharmaceutical marketing and patient support programs via its AI platform and patient-level data. AllazoHealth’s AI solution has proven incredibly effective in supporting a wide range of treatments, from diabetes and hypertension to cardiovascular and autoimmune conditions.
PM360 has recognized AllazoHealth specifically for its tremendous strides in applying its innovation where it’s perhaps needed most: for patients with rare diseases. AllazoHealth has partnered with one of the top 10 rare diseases companies in the world to personalize the patient experience at the individual level. Case studies in specialty medications have shown a 9.4 percent increase in initiation rates over a 90-day period for an immunology biologic and a 14 percent increase in days on therapy for a major depressive disorder medication.
“Being featured in the 2023 PM360 Innovation Issue under the AI category, AllazoHealth is not just recognized, but it’s also a testament to our team’s impact on patients,” says AllazoHealth CEO Bill Grambley. “This acknowledgment fuels our passion for pushing the boundaries of AI in life science and we’re grateful to PM360 for spotlighting our commitment to shaping the future of healthcare through groundbreaking technology.”
“We know the importance of innovation, which is why we expanded this issue to include the most fascinating and ground-breaking achievements being made in all areas of life sciences, healthcare, and marketing,” says Anna Stashower, CEO, Publisher, and Editor-in-Chief of PM360. “The innovations we selected are changing how our industry operates to create better ways to develop treatments, run companies, educate physicians, improve diagnosis, and much more to ultimately find better ways to serve patients.”
AllazoHealth, along with all of this year’s PM360 Innovations Issue selections can be found at: https://www.pm360online.com/pm360-presents-the-2023-innovators.
About AllazoHealth
AllazoHealth is the pioneer in delivering AI-driven healthcare experiences. Through its award-winning artificial intelligence (AI) platform and patient-level data, AllazoHealth empowers pharmaceutical organizations to personalize interventions and create the optimal experience for each individual, maximizing the impact and efficiency of pharmaceutical marketing and patient support programs. AllazoHealth’s breakthrough technology currently helps its healthcare customers and partners to improve medication initiation, adherence, and health outcomes for millions of people across the United States. Learn more at AllazoHealth.com
About PM360
PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.